腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)活性蛋白
Active Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
CD253; TNFSF10; APO2L; Apo2-L; TL2; TRAIL; Tumor Necrosis Factor Ligand Superfamily Member 10; Apo-2 Ligand
- 編號UAPA139Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液（pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300）
- 性狀液體
- 純度> 95%
- 等電點8.6
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 462 ¥ 1155 ¥ 2310 ¥ 6930 ¥ 17325
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Gene sequencing
-
SDS-PAGE圖
-
Figure. Western Blot; Sample: Recombinant TRAIL, Human.
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
活性實驗
Protein TRAIL (TNF-Related Apoptosis-Inducing Ligand) is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. TRAIL induces apoptosis in transformed and tumor cells. This protein binds to several members of TNF receptor superfamily including TNFRSF10B/TRAILR2. Thus a binding ELISA assay was conducted to detect the interaction of TRAIL and TNFRSF10B. Briefly, recombinant human TRAIL were diluted serially in PBS, with 0.01%BSA (pH 7.4). Duplicate samples of 100uL were then transferred to TNFRSF10B-coated microtiter wells and incubated for 2h at 37°C. Wells were washed with PBST and incubated for 1h with anti-TRAIL pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37°C. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of TRAIL and TNFRSF10B was shown in Figure 1, and this effect was in a dose dependent manner.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPA139Hu01 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA139Hu02 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA139Hu01 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)活性蛋白 | Cell?culture;?Activity?Assays. |
| UPAA139Hu01 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAA139Hu02 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAA139Hu71 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| ULAA139Hu81 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| UMAA139Hu25 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體 | WB |
| UMAA139Hu24 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體 | WB |
| UMAA139Hu22 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體 | WB |
| UMAA139Hu21 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體 | WB |
| UMAA139Hu23 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體 | WB; ICC/IF |
| ULAA139Hu72 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體(生物素標記) | WB |
| ULAA139Hu82 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| USEA139Hu | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA139Hu | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA139Hu | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UKSA139Hu01 | 腫瘤壞死因子相關(guān)凋亡誘導配體(TRAIL)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| PLOS ONE | Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model [Pubmed:25506835] |
| PLOS ONE | Soluble TRAIL Concentration in Serum Is Elevated in People with Hypercholesterolemia [PubMed: 26633016] |
| Scientific Reports | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice [pubmed:28507343] |
| Journal of Molecular Medicine | TRAIL and TRAIL Receptors as Prognostic Markers in Breast Cancer Patients [Pubmed: 31183506] |
| life sciences | Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNk/caspase-8/TRAIL activation in rats [Pubmed: 32259601] |
| Int Immunopharmacol | Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling [Pubmed: 33199237] |
| ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY | Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways [Pubmed: 32942000] |
| J Biochem Mol Toxicol | Tranilast abrogates cisplatin?\induced testicular and epididymal injuries: An insight into its modulatory impact on apoptosis/proliferation [34047436] |
